4-acryloylmorpholine,
4-Acryloylmorpholine,
1-Morpholinoprop-2-en-1-one,
5117-12-4,
N-Acrylylmorpholine,
N-Acryloylmorpholine,
Morpholine, 4-(1-oxo-2-propenyl)-,
Poly(acryloylmorpholine),
acryloylmorpholine,
ACRYLOYL MORPHOLINE,
UNII-K0Y58P61JA,
K0Y58P61JA,
4-(1-Oxo-2-propenyl)morpholine,
XLPJNCYCZORXHG-UHFFFAOYSA-N,
MFCD00047413,
1-(Morpholin-4-yl)prop-2-en-1-one,
2-Propen-1-one, 1-(4-morpholinyl)-,
Pacm-I,
Acryloyl-morpholine polymer,
Poly(N-acryloyl morpholine),
N-Acrolylmorpholine,
4-AcryloYl-Morpholine,
4-Acryloylmorpholine #,
ACMC-1AMXH,
AC1L40DL,
AC1Q2A9A,
DSSTox_CID_24947,
DSSTox_RID_80607,
DSSTox_GSID_44947,
SCHEMBL36422,
(1-oxo-2-propenyl)morpholine,
AC1Q2A99,
SCHEMBL9914378,
CHEMBL3187188,
DTXSID0044947,
CTK5J3079,
KS-00000VSW,
4-(1-oxo-2-propenyl)-morpholine,
1-morpholin-4-ylprop-2-en-1-one,
ZINC1623625,
Tox21_301658,
7111AB,
ANW-54531,
NSC162221,
AKOS005207052,
NSC-162221,
NCGC00256280-01,
28902-82-1,
AJ-28383,
CJ-26171,
DA-05336,
CAS-5117-12-4,
DB-051915,
RT-001645,
A0841,
FT-0629859,
EC 418-140-1,
Morpholine, 4-(1-oxo-2-propenyl)-, homopolymer,
I14-7166,
InChI=1/C7H11NO2/c1-2-7(9)8-3-5-10-6-4-8/h2H,1,3-6H,
4-Acryloylmorpholine, 97%, contains 1,000 ppm monomethyl ether hydroquinone as inhibitor,
4-Acryloylmorpholine, 97%,
C7H11NO2,
(C7-H11-N-O2)x-,
CID98723,
AR-1K5849,
4-Acryloylmorpholine, 98% - 25ML 25ml,
3692-27-1,